Pituitary cyclase-activating polypeptide targeted treatments for the treatment of primary headache disorders.
Nazia KarsanLars EdvinssonLaszlo VecseiPeter J GoadsbyPublished in: Annals of clinical and translational neurology (2024)
Future clinical trials hold considerable promise for a new therapeutic approach using PACAP-targeted therapies in both migraine and cluster headache.